Stifel maintains Buy rating on Contineum Therapeutics stock despite MS trial failure
Investing.com - Rosenblatt Securities raised its price target on Arteris, Inc (NASDAQ:AIP) to $20 from $14 while maintaining a Buy rating following the company’s quarterly earnings report. Despite the optimistic outlook, InvestingPro data shows the stock has fallen 9.48% over the past week, though it maintains an impressive 72.07% return over the last year.
The network-on-chip intellectual property provider delivered what Rosenblatt described as a "beat-n-raise report," featuring expanded licenses with both Altera and AMD, along with new FlexGen license additions. With a remarkable 90.03% gross profit margin, Arteris demonstrates strong pricing power in its intellectual property business.
Rosenblatt highlighted that over 50% of Arteris’ third-quarter 2025 licensing revenue came from artificial intelligence applications, spanning both data centers and smart network edge deployments.
The firm noted that two key industry trends are driving demand for Arteris’ intellectual property: the increasing need for chiplets and the move toward smaller process geometries in semiconductor manufacturing.
Rosenblatt expressed confidence in the momentum Arteris is building, which factored into its decision to raise the 12-month price target while maintaining its Buy recommendation on the stock.
In other recent news, Arteris Inc. announced its financial results for the third quarter of 2025, reporting a revenue of $17.4 million. This marks an 18% increase compared to the same period last year, surpassing the projected revenue of $17 million. The company’s earnings per share (EPS) were in line with expectations, recorded at -$0.09. These developments highlight a positive trend in revenue growth for the company. Despite this revenue increase, the stock experienced a decline in aftermarket trading. Arteris’ stock closed at $12.41, which was a 5.88% drop. This recent performance indicates the market’s mixed reaction to the company’s financial outcomes. Investors may want to consider these developments as they evaluate their investment strategies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.